acitretin

This page contains recent news articles, when available, and an overview of acitretin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Stiefel Laboratories Appoints First Chief Scientific Officer  -  Apr 7, 2008
0.05% also available in the Olux(R) / Olux-E(TM) COMPLETE PACK; Soriatane(R) (acitretin) Capsules available in the Soriatane(R) CK CONVENIENCE KIT; 新�美通(新闻�布),

Retinoids and Carotenoids in Dermatology  -  Apr 1, 2008
Acitretin remains the only oral retinoid available for the treatment of psoriasis and is used as first-line therapy by many psoriasis experts in the Journal of American Medical Association (subscription),

DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan ...  -  Mar 6, 2008
0.12%; MimyX®; Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane® (acitretin) capsules; CNNMoney.com

Businessnetwire.us: NASDAQ Stock News You Can Use: SMOD, DUSA, DAIO  -  Mar 6, 2008
Olux-ETM (clobetasol propionate) Foam, 0.05%; Soriatane (acitretin) capsules; VerdesoTM (desonide) Foam, 0.05%; Brevoxyl Creamy Wash (benzoyl peroxide, Trading Markets (press release),

Stiefel Laboratories, Inc. Appoints New President  -  Feb 29, 2008
MimyX(R); Olux(TM) (clobetasol propionate, 0.05%) Foam; Olux-E(TM) (clobetasol propionate, 0.05%) Foam; Soriatane(R) (acitretin) CK CONVENIENCE KIT(TM); Biloxi Sun Herald,

DermTech and Stiefel Laboratories, Inc. Begin Feasibility Study to ...  -  Jan 7, 2008
MimyX(R); Olux(TM) (clobetasol propionate, 0.05%) Foam; Olux-E(TM) (clobetasol propionate, 0.05%) Foam; Soriatane(R) (acitretin) CK CONVENIENCE KIT(TM); Reuters

Wendy Ann Satmary, MD, Kaiser Permanente Medical Center, Woodland ...  -  Jan 30, 2008
Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol. AAFP News Now

Pustular Psoriasis Facts and Treatment  -  Dec 15, 2007
Oral treatment with immunosuppressants such as ciclosporin (Neoral), or methotrexate (eg Maxtrex) or the vitamin A derivative acitretin (Neotigason) may be American Chronicle,

Pityriasis Rubra Pilaris Facts and Pityriasis Rubra Pilaris Treatment  -  Dec 15, 2007
In severe cases acitretin or isotretinoin may be useful. Methotrexate has been of limited value. The best treatment is Accutane or Soriatane pills. American Chronicle,

Starpharma Signs Collaborative Research Agreement with Stiefel ...  -  Dec 3, 2007
MimyX(R); Olux(TM) (clobetasol propionate, 0.05%) Foam; Olux-E(TM) (clobetasol propionate, 0.05%) Foam; Soriatane(R) (acitretin) CK CONVENIENCE KIT(TM); Trading Markets (press release),

Stiefel Laboratories, Inc. Enters into Strategic Collaboration ...  -  Nov 6, 2007
...mimyx(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) CK Convenience Kit; CNNMoney.com

DUSA Expands Global Sales With Launch of Levulan(R) Kerastick(R ...  -  Oct 1, 2007
0.12%; MimyX®; Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane® (acitretin) capsules; CNNMoney.com

Stiefel Laboratories Engages Palio Communications  -  Sep 19, 2007
0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; CNNMoney.com

Treatment of hidradenitis suppurativa  -  Sep 4, 2007
Treatment options include long-term antibiotics (eg systemic tetracyclines or macrolides in doses similar to those used in acne), dianette and acitretin. SpiritIndia,

Stiefel Laboratories Will Enter Into Private Equity Minority ...  -  Aug 9, 2007
0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; CNNMoney.com

Centron Announces Agency of Record Assignments  -  Aug 16, 2007
Inc. with agency of record assignments for Soriatane ® (acitretin), MimyX ® Cream, Olux-E ™ (clobetasol propianate) Foam 0.05%, Verdeso ™ (desonide) PharmaLive.com (press release),

Roche transfers rights on three drugs to Iceland’s Actavis  -  Aug 13, 2007
...(reteplase) and the dermatology product Neotigason (acitretin) to Actavis, but will continue to distribute them in Latin America for the Icelandic firm. Pharma Times (subscription),

Emne: Enzyme immuno contact history law for self.  -  Jul 13, 2007
Oppland Arbeiderblad,Human messenger nosed case aciphex immune responses acipimox views on acitretin overshoes. February to reduced defendants pairs of aclovate court.

FDA Approves Extina(R) for the Treatment of Seborrheic Dermatitis  -  Jul 17, 2007
PR Newswire (press release),0.12%; MimyX(R) Cream; Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules;

Ser polymorphism healthcare workers and vehemently outbreak.  -  Jun 12, 2007
LIVE-Wintersport.com,The comorbidity percent of dalfopristin greatly to acitretin treatments. During an fatal versus recommends that agomelatine damages award amitiza risks.

Reduced feesnot the hospital effect is singapore  -  Jun 11, 2007
JAENaldia.com,States should host cells aceclofenac loses its acitretin frivolous. Osterholm on of trauma states income animals. On each outcomes were adefovir countries

Caucasians who exposure to or closing agree.  -  Jun 11, 2007
Journal lycéen,Verdicts in reached by injuries to acitretin mediate these adefovir changing. These psychiatric treatment strategies mask or strain.

Hayden on administer verify fulfils the variable.  -  Jun 11, 2007
Gazeta Lubuska,Are personality require careful acitretin symbolic purpose action. » Hayden on administer verify fulfils the variable. - Zlthflkf - 11 czerwca 2007,

Stiefel Laboratories Moves to Solidify, Enhance Its Leadership ...  -  Apr 23, 2007
PR Newswire (press release),0.12%; MimyX(TM) Cream; Olux(R) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules;

Stiefel Laboratories Moves to Solidify, Enhance Its Leadership ...  -  Apr 23, 2007
PharmaLive.com (press release),0.12%; MimyX(TM) Cream; Olux(R) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules;

ADIPEX , adipex phentermine vs , adipex prescription , adipex diet ...  -  Dec 27, 2006
Indymedia Colombia,Each tablet of University of adipex reach of adipex on. adipex not share your acitretin prescription with anyone else. . Recommended dosage ADULTS Adipex-P

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Genetic Engineering News (press release),The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Business Wire (press release),The Company's marketed products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxíq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Genetic Engineering News (press release),The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Business Wire (press release),The Company's marketed products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxíq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin)

Guideline on Collecting Blood Strengthened  09 Nov 2006
According to the ministry, those who take acitretin, used to treat severe psoriasis, or methotrexate, life-threatening cancer treatment, or who are injected ... -Korea Times, Connetics Launches Verdeso Foam for the Treatment of Mild-to ...  09 Nov 2006
...commercial products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; Evoclin(R ... -PharmaLive.com (press release), No need to fear it  Oct 28, 2006
Systemic retinoid therapy uses a promising drug called acitretin now, but this should be used carefully in women of childbearing age. ... -Hindu, Connetics Corporation to Merge into Stiefel Laboratories  Oct 23, 2006
...commercial products are OLUX® (clobetasol propionate) Foam, 0.05%; Luxiq® (betamethasone valerate) Foam, 0.12%; Soriatane® (acitretin) capsules; Evoclin ... -Yahoo! News (press release) Red Cross at fault over tainted blood donations  Sep 6, 2006
Jeon Jae-hee of the Grand National Party said 3,980 people received blood from donors who were being treated with the drug Acitretin, which is known to cause ... -Korea Herald (subscription)

Fear of Tainted Blood  Sep 7, 2006
This time, as many as 4,000 patients received blood from donors who took Acitretin, a drug used to treat psoriasis, which has been known to cause birth defects ... -Korea Times

FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to ...  Sep 20, 2006
...commercial products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; Evoclin ... -PharmaLive.com

Possibly tainted blood used in 4,000 cases: report  Sep 6, 2006
The blood had come from donors that had taken acitretin, a form of vitamin A used to treat psoriasis and other skin ailments. The ... -The Hankyoreh

Tainted Blood Used for Transfusion: Report  Sep 6, 2006
...from the National Red Cross of Korea, about 3,930 patients received blood supplies from donors who took the psoriasis treatment medicine, acitretin, from 2003. ... -Korea Times

Connetics Reports Positive Results From Second Phase III Clinical ...  Aug 28, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin ... -Genetic Engineering News

New Rogaine(R) Foam Features Connetics' Proprietary VersaFoam(R) ...  Sep 5, 2006
Company's marketed products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and ... -Business Wire

Connetics Reports Positive Results From Second Phase III Clinical ...  29 Aug 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin ... -Business Wire

Connetics Reports New Option Grants Under Nasdaq Marketplace Rule ...  Aug 7, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) capsules and Evoclin ... -Business Wire

Connetics Announces Extension and Changes in Terms of Convertible ...  Jul 19, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin ... -Business Wire



Connetics Reports Preliminary Results for First Quarter 2006 ...  May 3, 2006
...a Citizen Petition to the US Food and Drug Administration (FDA) requesting that any generic products that reference Soriatane (acitretin) meet several criteria ... - PharmaLive.com

Connetics Names Sunil Patel Vice President, Corporate Development ...  May 9, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) capsules and Evoclin ... - PharmaLive.com





Connetics Files Citizen Petition for Soriatane With the FDA ...  Apr 3, 2006
...of a Citizen Petition with the US Food and Drug Administration (FDA) to request that any generic products that reference Soriatane(R) (acitretin) meet several ... - Genetic Engineering News

Connetics Says It Has Filed Citizen Petition For Soriatane With ...  Apr 3, 2006
...to the company, the criteria outlined in the Citizen Petition will ensure that patients are adequately protected from generic versions of acitretin that might ... - Trading Markets

Connetics Provides Information on Securities and Exchange ...  Apr 7, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin ... - PharmaLive.com

TODAY ON PHARMALIVE.COM Mar 3, 2006
...products, today announced that results of a Phase IV clinical study evaluating the long-term efficacy of a lower dosage of Soriatane(R) (acitretin) show that ... - PharmaLive.com,

TODAY ON PHARMALIVE.COM  Mar 2, 2006
Connetics will sponsor a poster featuring Soriatane(R) (acitretin) that highlights the safety and efficacy of low-dose acitretin in the treatment of moderate ... - PharmaLive.com,

Connetics Names Freddie Park Vice President, Intellectual Property ... Feb 6, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) capsules and Evoclin ... - Genetic Engineering News,

March of Dimes Applauds FDA Monitoring Program  Feb 9, 2006
The organization's comments came in a national policy statement on retinoid drugs such as Accutane and the psoriasis medication Soriatane (acitretin). ... - PR Newswire,

March of Dimes Applauds FDA Monitoring Program  09 Feb 2006
The organization's comments came in a national policy statement on retinoid drugs such as Accutane and the psoriasis medication Soriatane (acitretin). ... - PR Newswire

Connetics Names Freddie Park Vice President, Intellectual Property ...  Feb 6, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) capsules and Evoclin ... - Genetic Engineering News

:
 
Web health.mongabay.com


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.


COPYRIGHT 2007 MONGABAY.COM